• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上腔静脉综合征的血管内治疗

Endovascular treatment of superior vena cava syndrome.

作者信息

Duvnjak S, Andersen P

机构信息

Department of Radiology, Odense University Hospital, Odense, Denmark.

出版信息

Int Angiol. 2011 Oct;30(5):458-61.

PMID:21804485
Abstract

AIM

The aim of this study was to report our experience with palliative stent treatment of superior vena cava syndrome.

METHODS

Between January 2008 and December 2009, 30 patients (mean age 60.7 years) were treated with stents because of stenosed superior vena cava. All patients presented clinically with superior vena cava syndrome and according caval stenosis confirmed by computed tomography. The causes of stenoses were non-small cell carcinoma in 22 patients and small cell carcinoma in 8 patients.

RESULTS

In all patients the stents were placed as intended in all patients there was an immediate clinical improvement with considerable reduction in the edema of upper extremities and head. There was, however, continous dyspnea in five patients (17%) and two patients (7%) had persistent visible collateral venous circulations on the upper chest. There were no stent associated complications. All patients were followed clinically till death and the median follow-up period was 2.8 months (15-420 days). During follow-up three cases of stent thrombosis (one complete and two partial thrombosis) were observed.

CONCLUSION

Palliative care with stent implantation for superior vena cava syndrome is a minimal invasive and safe procedure with good clinical effect giving the patients a significant better quality of their residual life.

摘要

目的

本研究旨在报告我们采用姑息性支架治疗上腔静脉综合征的经验。

方法

2008年1月至2009年12月期间,30例(平均年龄60.7岁)因上腔静脉狭窄接受支架治疗。所有患者临床上均表现为上腔静脉综合征,且经计算机断层扫描证实存在腔静脉狭窄。狭窄原因包括22例非小细胞癌和8例小细胞癌。

结果

所有患者的支架均按计划置入,所有患者临床症状立即改善,上肢和头部水肿明显减轻。然而,5例患者(17%)仍持续存在呼吸困难,2例患者(7%)上胸部可见持续的侧支静脉循环。未发生与支架相关的并发症。所有患者均接受临床随访直至死亡,中位随访期为2.8个月(15 - 420天)。随访期间观察到3例支架血栓形成(1例完全血栓形成和2例部分血栓形成)。

结论

对上腔静脉综合征进行支架植入姑息治疗是一种微创且安全的手术,临床效果良好,能显著提高患者剩余生命的质量。

相似文献

1
Endovascular treatment of superior vena cava syndrome.上腔静脉综合征的血管内治疗
Int Angiol. 2011 Oct;30(5):458-61.
2
Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.支架置入术作为恶性上腔静脉综合征血管内治疗的首选方法。
AJR Am J Roentgenol. 2001 Sep;177(3):585-93. doi: 10.2214/ajr.177.3.1770585.
3
A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.一种用于上腔静脉综合征的新型镍钛合金支架。初步临床经验。
J Cardiovasc Surg (Torino). 2015 Dec;56(6):877-81. Epub 2015 Jul 27.
4
Endovascular Treatment of Superior Vena Cava Syndrome via Balloon-in-Balloon Catheter Technique with a Palmaz Stent.经皮球囊扩张式导管技术联合Palmaz支架治疗上腔静脉综合征的血管内治疗
Tex Heart Inst J. 2016 Dec 1;43(6):520-523. doi: 10.14503/THIJ-15-5479. eCollection 2016 Dec.
5
Pericardial tamponade after superior vena cava stent: are nitinol stents safe?上腔静脉支架置入术后心包填塞:镍钛合金支架安全吗?
Asian Cardiovasc Thorac Ann. 2010 Jun;18(3):294-6. doi: 10.1177/0218492310368730.
6
Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents.亚急性和慢性良性上腔静脉梗阻:自膨式金属支架的血管内治疗
AJR Am J Roentgenol. 1999 Jul;173(1):159-64. doi: 10.2214/ajr.173.1.10397119.
7
Extensive distortion and dysfunction of an Edwards Valeo Lifestent placed for stenosis of the superior vena cava.爱德华兹·瓦莱奥生命瓣(Lifestent)用于治疗上腔静脉狭窄,发生严重变形和功能障碍。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):282-5. doi: 10.1002/ccd.23088. Epub 2011 Jul 15.
8
[Superior vena cava thrombosis or stricture secondary to implanted central venous access: Six cases of endovascular and direct surgical treatment in cancer patients].[植入式中心静脉通路继发上腔静脉血栓形成或狭窄:癌症患者的6例血管内及直接手术治疗]
J Med Vasc. 2018 Feb;43(1):20-28. doi: 10.1016/j.jdmv.2017.11.001. Epub 2017 Dec 26.
9
The treatment of superior vena cava syndrome secondary to idiopathic fibrosing mediastinitis with balloon angioplasty and stenting.球囊血管成形术和支架置入术治疗特发性纤维性纵隔炎继发的上腔静脉综合征
Am Surg. 2012 Dec;78(12):1405-6.
10
Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.经上肢入路行血管内治疗恶性上腔静脉综合征:静脉专用支架与传统支架的比较。
J Vasc Interv Radiol. 2020 Dec;31(12):2066-2072. doi: 10.1016/j.jvir.2020.08.007. Epub 2020 Oct 27.

引用本文的文献

1
Superior vena cava stenosis presenting with bendopnea.上腔静脉狭窄伴弯腰呼吸困难。
BMJ Case Rep. 2021 Apr 21;14(4):e242418. doi: 10.1136/bcr-2021-242418.
2
Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.经双静脉入路应用血管内支架进行再血管化治疗恶性上腔静脉综合征并同期植入端口装置
Support Care Cancer. 2018 Jun;26(6):1881-1888. doi: 10.1007/s00520-017-3997-9. Epub 2017 Dec 22.
3
The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients.
透析患者中心静脉闭塞的贯穿钢丝技术的可行性和安全性。
BMC Cardiovasc Disord. 2016 Dec 7;16(1):250. doi: 10.1186/s12872-016-0411-3.
4
Palliative treatment of superior vena cava syndrome with nitinol stents.镍钛合金支架治疗上腔静脉综合征的姑息治疗
Int J Angiol. 2014 Dec;23(4):255-62. doi: 10.1055/s-0034-1383432.
5
Malignant superior vena cava syndrome.恶性上腔静脉综合征
Urol Ann. 2013 Oct;5(4):294-5.